Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. - Wikidata - wikimedia - TriplyDB

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.

http://www.wikidata.org/entity/Q38275572

about

MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours Expression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigen Sperm protein 17 is expressed in human nervous system tumours.Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Cancer/testis antigens, gametogenesis and cancer Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients.Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors Expression of cancer-testis (CT) antigens in placenta.Cancer-testis (CT) antigen expression in medulloblastoma.Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma.Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.Cancer/testis (CT) antigens are expressed in fetal ovary.Centrosomal localisation of the cancer/testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition.Epigenetic targets for immune intervention in human malignancies.Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.Expression of cancer-testis antigens in hepatocellular carcinoma.Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.Cancer-testis antigen expression and immunogenicity in AL amyloidosis.Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era.Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.Cancer-testis antigens in haematological malignancies.Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103.Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Breast cancer stem cells: implications for therapy of breast cancer.The evolving role of dendritic cells in cancer therapy.The biology of cancer testis antigens: putative function, regulation and therapeutic potential Cancer-testis antigens: the current status on antigen regulation and potential clinical use.Decitabine: a promising epi-immunotherapeutic agent in solid tumors.Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients.Human Microtumors Generated in 3D: Novel Tools for Integrated In Situ Studies of Cancer Immunotherapies.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Endogenous, very small embryonic-like stem cells: critical review, therapeutic potential and a look ahead.MAGE-A9 mRNA and protein expression in bladder cancer.Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues.

P2860

Q24300816-4BFD946B-BE1F-46EA-806D-E06BB618A628 Q24301553-6BB005A3-757B-43DF-BC4E-55D36C9E07EF Q24647085-AD971B03-C0F6-40FE-A7CA-CAD1CA8CE058 Q24652084-1DCD7C3C-900F-4423-8E50-89B6BC42A154 Q25256674-17C953D0-ACEC-4BEB-8A39-9B4E0D475C2A Q28188712-CD7045ED-2F26-44E4-B1AC-763C3BE30D8B Q28215652-F4BBCA6F-7A83-458B-9299-4722B6D873BD Q29616129-F2544FF3-CE53-46AB-A2A1-587BF36D0B55 Q30706370-4D37382F-CCB6-4B5A-81BA-C6A0A3A62517 Q34032518-E3FF934A-6B06-439E-A0D7-EBEAC78EA6BC Q34111725-D513BD16-2E9E-4FDF-8A87-470FA41A5635 Q34111764-A0B195DA-9079-4264-A4A7-0831EC70BADF Q34111864-6BE77209-4772-4CF1-94DA-7649C4CD26CD Q34503895-AC0762C2-F702-4B1A-A188-0A3E2022EFA1 Q34753747-565A5C53-7137-4F9C-93C2-0EDE263F1BF2 Q34797637-1E04F083-05DA-4CED-BC93-C0D36499C158 Q35067995-F7459D1A-A0F8-4279-8327-EA52C238009B Q35257918-11A575FA-0A01-4FF3-A56F-A5EB37F492E3 Q35551107-29193FF5-CFCE-4F6D-8D00-376773AC3C89 Q35733359-5F6D8B9F-83AB-4B4D-B974-D7D1E7A2A283 Q36066187-6993B3B1-E775-4809-A4F7-4CB8BB1C8293 Q36086874-CE8286F0-A0E9-4DDE-A0C3-461A270F8F9A Q36289604-25DDB27B-63D9-4BC2-A740-AE131E671ED8 Q36316627-984F1A15-C7D5-441D-87D2-62827E6257F4 Q36614408-300A8072-DFBD-4E16-89FE-BAE79F32C967 Q36708379-4F343AD1-2E88-4A3B-8CAA-C163514597EB Q36786757-F6085352-7227-4F80-B760-85703E447721 Q36801625-F7738910-C738-43ED-8C1E-A263528C77C8 Q36918233-DB42D71C-78EC-4F9C-89E3-17AF56466333 Q36955061-E5DE869B-CA7B-4115-896A-CA86C2AC2272 Q37687418-2FA0FFC4-1A79-411C-A1AD-D2BF7C9FEBAC Q37849976-7FDC9265-5DF1-4230-9CF4-87F8784C2A1E Q37995200-2F0F4EA2-EC12-4581-BA2F-AD010E753E7C Q38314204-8E8938F1-2A02-4993-BA0F-9A732FE12004 Q38403243-C259F1E6-525C-4099-B1DD-507F5BFCDC0D Q38782039-ABEA54F9-922C-4B69-9E75-C7DA28520240 Q38948541-B3E7DCF9-4066-495A-9860-EA17F9880FE8 Q38950926-60C193BC-6690-4A6F-95DA-023F109D5388 Q40172793-15B58964-8862-414B-9E3F-FDFFA759C6D8 Q40484689-40164B8E-7FA4-4E21-A0DE-B86100A3E362

P2860

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.

http://www.wikidata.org/entity/Q38275572

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Monoclonal antibody MA454 reve ...... araffin embedded lung tumours.

@en

type

label

Monoclonal antibody MA454 reve ...... araffin embedded lung tumours.

@en

prefLabel

Monoclonal antibody MA454 reve ...... araffin embedded lung tumours.

@en

P1433

Q38275572-C4323E6D-3396-48B1-B710-55CF50A05EA3

P1476

Q38275572-D0FB7BCC-9CC9-4E69-A7A9-3695A09AF1E5

P2093

Q38275572-194C45B8-243D-4786-8812-C7251DB03AE1

Q38275572-5C8A0C58-ACAB-4D41-8286-8F4BE5381983

Q38275572-8696B124-6A88-449D-B63F-22506E04077D

Q38275572-A0BB1203-C23A-4CE4-AD68-FB6B18AA54AA

Q38275572-A4212D6D-D5D0-4B78-9CCB-6E735AEDFDF9

Q38275572-AD13935F-9921-4281-9036-084A9D20D34C

Q38275572-C416A876-B2F1-4221-A0F6-D2CBA3F2F690

Q38275572-DD809366-DF30-43B6-9043-48B17E1DA535

Q38275572-E7B24CF6-DBF4-4EF1-9234-FA1BB1291198

Q38275572-FE08B6D7-2A1F-4452-BEA0-08535E091522

P2860

Q38275572-0AA5D06E-1CEC-44E7-A9FC-5F07D3F285BC

Q38275572-0C3D3B6A-CAC1-470C-9B1F-C08D8517502F

Q38275572-1DEFFA8D-DDE5-432D-BC98-D924C9F56C65

Q38275572-3FFE2621-ECEB-46C3-B37D-6D7686903F48

Q38275572-48BCF3B0-67BF-43D3-AA3C-A0B25F724207

Q38275572-5FF6C809-5D63-4355-8B5A-69A8793401DA

Q38275572-9FFDA874-9B28-4583-B508-AA07D55EE361

Q38275572-A0255CD2-558E-4C03-8FC9-D864D2C7FBD7

Q38275572-ACCAF3E4-FD31-4BFC-9BAF-24E95D929D09

Q38275572-AFDDC9C4-E031-40F1-A037-4E1D5CCB79E1

P2888

Q38275572-B2F91C92-F002-4AE0-A4EE-027231DAD968

P304

Q38275572-79B40B71-D8E0-4097-A9DA-36CBBF810ABA

P31

Q38275572-A9796933-1FD4-46E3-93A6-66B1840A16EE

P356

Q38275572-BCEE343F-AAF3-4FD4-A960-F3B382313287

P407

Q38275572-3B77B810-0CA0-4236-8918-6DEE2E0225D1

P433

Q38275572-E56AB5C3-23E4-4366-85C3-952E644B32B2

P478

Q38275572-E31DC116-055E-4187-B2C3-823D31C9AFD2

P577

Q38275572-AFB2C188-3B9E-4CBC-911D-6BE9992BB483

P5875

Q38275572-51578F98-9BB0-47A8-9A5D-D6AA34B98666

P6179

Q38275572-24A65123-C3B9-4396-B507-6CF4AEF4C47B

P698

Q38275572-A3722BEE-2077-4120-A19C-41AD180251EF

P921

Q38275572-E090F993-9915-459C-ABE3-A0A1C88CCFCA

P932

Q38275572-D386FFB5-F1CA-44DD-B3B0-1BE4C97A046D

P356

P1433

British Journal of Cancer

P1476

Monoclonal antibody MA454 reve ...... araffin embedded lung tumours.

@en

P2093

Altorki N

http://www.w3.org/2001/XMLSchema#string

Busam KJ

http://www.w3.org/2001/XMLSchema#string

Chen YT

http://www.w3.org/2001/XMLSchema#string

Coplan K

http://www.w3.org/2001/XMLSchema#string

Iversen K

http://www.w3.org/2001/XMLSchema#string

Jungbluth AA

http://www.w3.org/2001/XMLSchema#string

Kolb D

http://www.w3.org/2001/XMLSchema#string

Old LJ

http://www.w3.org/2001/XMLSchema#string

Stockert E

http://www.w3.org/2001/XMLSchema#string

Williamson B

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

Identification of a new MAGE gene with tumor-specific expression by representational difference analysis

MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus

Identification and intracellular location of MAGE-3 gene product

Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis.

MAGE-1 gene product is a cytoplasmic protein.

Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins.

MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.

P2888

P304

493-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2000.1291

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12374290

http://www.w3.org/2001/XMLSchema#string

P6179

1001360758

http://www.w3.org/2001/XMLSchema#string

P698

10945497

http://www.w3.org/2001/XMLSchema#string

P921

P932

2374655

http://www.w3.org/2001/XMLSchema#string